GACP certification for cannabis growers is widely misunderstood. Learn what GACP conformance actually requires, how it differs from GMP and Canada’s GPP, and how it feeds EU-GMP export.
Read More
TGA Names Medicinal Cannabis a Compliance Priority, With New Vaping-Device Guidance
TGA medicinal cannabis is now a named 2026-27 compliance priority, and new 7 July vaping-device guidance raises scrutiny. What Australian producers and importers should do.
Read More
Cannabis Regulation in Costa Rica: Where the Law Stands
A source-cited guide to Costa Rica cannabis regulation: the medical and hemp verticals under Ley 10.113, the MAG/Salud/ICD licensing split, RTCR 515:2024, and where recreational cannabis stands.
Read More
Germany’s Proposed Medical Cannabis Crackdown: What a Telemedicine and Mail-Order Ban Would Mean
Germany’s Federal Cabinet backed a draft banning telemedicine prescriptions and mail-order supply of medical cannabis, but the reform stalled after its first reading. Here is what it means for suppliers, especially Canada.
Read More
Brazil’s Cannabis New Era Begins: ANVISA’s RDC 1,015 Takes Effect and Reshapes Latin America’s Largest Medical Market
Brazil’s medical cannabis industry entered a new chapter on May 4, 2026. After seven years under the provisional framework of RDC 327/2019, ANVISA’s…
Read More
Colombia Medical Cannabis Flower and the Adult-Use Push
Colombia now allows medical cannabis flower in pharmacies and is debating adult-use legalisation. Here is what producers need to know about licences, regulators and export readiness in 2026.
Read More